Use of the Perceval Sutureless Valve in Active Prosthetic Aortic Valve Endocarditis Elena Roselló-Díez, MD, Gregorio Cuerpo, MD, PhD, Francisco Estévez, MD, Christian Muñoz-Guijosa, MD, PhD, Manel Tauron, MD, José J. Cuenca, MD, Ángel González-Pinto, MD, PhD, Josep María Padró, MD, PhD The Annals of Thoracic Surgery Volume 105, Issue 4, Pages 1168-1174 (April 2018) DOI: 10.1016/j.athoracsur.2017.11.031 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Previous infected prosthesis in case 2, with dehiscence at left coronary sinus (large arrow) and previous pledgeted sutures (smaller arrow). The Annals of Thoracic Surgery 2018 105, 1168-1174DOI: (10.1016/j.athoracsur.2017.11.031) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Final appearance after Perceval S deployment in case 2. The Annals of Thoracic Surgery 2018 105, 1168-1174DOI: (10.1016/j.athoracsur.2017.11.031) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Mean transaortic gradient (TAG) at 6 months according to prosthesis size: small (S), medium (M), large (L), and extralarge (XL). The Annals of Thoracic Surgery 2018 105, 1168-1174DOI: (10.1016/j.athoracsur.2017.11.031) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Severity of aortic regurgitation (AoR) at 6 months. The Annals of Thoracic Surgery 2018 105, 1168-1174DOI: (10.1016/j.athoracsur.2017.11.031) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions